Molina Healthcare, Inc.
MOH · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.46 | 0.53 | 1.19 | -318.32 |
| FCF Yield | 3.26% | 7.52% | 3.57% | 11.11% |
| EV / EBITDA | 8.01 | 10.62 | 12.95 | 14.51 |
| Quality | ||||
| ROIC | 16.38% | 17.43% | 16.01% | 14.88% |
| Gross Margin | 11.65% | 12.72% | 12.28% | 11.81% |
| Cash Conversion Ratio | 0.55 | 1.52 | 0.98 | 3.22 |
| Growth | ||||
| Revenue 3-Year CAGR | 8.33% | 7.05% | 18.08% | 18.17% |
| Free Cash Flow Growth | -65.53% | 131.38% | -66.60% | 12.44% |
| Safety | ||||
| Net Debt / EBITDA | -0.82 | -1.41 | -1.20 | -1.82 |
| Interest Coverage | 14.47 | 14.43 | 10.66 | 8.50 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 16.09 | 17.89 | 14.71 | 16.06 |